HIV seroconversions among male non-occupational post-exposure prophylaxis service users: A data linkage study

Sexual Health

Volumn 8, Issue 2, 2011, Pages 179-183

  Pierce, Anna B ^a   Yohannes, Keflemariam ^b   Guy, Rebecca ^c   Watson, Kerrie M ^a   Armishaw, Jude ^a   Price, Brian ^a   Hoy, Jennifer F ^a,d   Wright, Edwina J ^a,b,d   Stoov́, Mark A ^b  

^a ALFRED HOSPITAL   (Australia)

^b BURNET INSTITUTE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

AIDS; Australia; HIV incidence; HIV prevention.

Indexed keywords

ADULT; AGE; ARTICLE; AUSTRALIA; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DISEASE REGISTRY; DISEASE SURVEILLANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MEDICAL RECORD; NON OCCUPATIONAL POST EXPOSURE PROPHYLAXIS; POST EXPOSURE PROPHYLAXIS; PREDICTIVE VALUE; RISK ASSESSMENT; SEROCONVERSION;

ADULT; ANTI-HIV AGENTS; AUSTRALIA; HIV INFECTIONS; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMANS; MALE; POST-EXPOSURE PROPHYLAXIS; RISK REDUCTION BEHAVIOR; VICTORIA;

EID: 79957533623     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH10063     Document Type: Article

References (22)

1. Poynten IM, Smith DE, Cooper DA, Kaldor JM, Grulich AE. The public health impact of widespread availability of nonoccupational postexposure prophylaxis against HIV. HIV Med 2007; 8: 374-81. doi:10.1111/j.1468-1293.2007.00483.x (Pubitemid 47163269)
2. Bryant J, Baxter L, Hird S. Non-occupational postexposure prophylaxis for HIV: a systematic review. Health Technol Assess 2009; 13: 1-60.
3. Pinkerton SD, Martin JN, Roland ME, Katz MH, Coates TJ, Kahn JO. Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States. AIDS 2004; 18: 2065-73. doi:10.1097/00002030-200410210-00011 (Pubitemid 39463360)
4. Pinkerton SD, Holtgrave DR, Bloom FR. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. AIDS 1998; 12: 1067-78. doi:10.1097/00002030-199809000-00014 (Pubitemid 28276975)
5. Guinot D, Ho MT, Poynten IM, McAllister J, Pierce A, Pell C, et al. Cost-effectiveness of HIV nonoccupational post-exposure prophylaxis in Australia. HIV Med 2009; 10: 199-208. doi:10.1111/j.1468-1293. 2008.00670.x
6. Loutfy MR, Macdonald S, Myhr T, Husson H, Du Mont J, Balla S, et al. Prospective cohort study of HIV post-exposure prophylaxis for sexual assault survivors. Antivir Ther 2008; 13: 87-95. (Pubitemid 351541677)
7. Kahn JO, Martin JN, Roland ME, Bamberger JD, Chesney M, Chambers D, et al. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP study. J Infect Dis 2001; 183: 707-14. doi:10.1086/318829 (Pubitemid 32171744)
8. Mayer KH, Mimiaga MJ, Cohen D, Grasso C, Bill R, Van Derwarker R, et al. Tenofovir DF plus lamivudine or emtricitabine for nonoccupational postexposure prophylaxis (NPEP) in a Boston Community Health Center. J Acquir Immune Defic Syndr 2008; 47: 494-9. doi:10.1097/QAI.0b013e318162afcb (Pubitemid 351366963)
9. Poynten IM, Jin F, Mao L, Prestage GP, Kippax SC, Kaldor JM, et al. Nonoccupational postexposure prophylaxis, subsequent risk behaviour and HIV incidence in a cohort of Australian homosexual men. AIDS 2009; 23: 1119-26. doi:10.1097/QAD.0b013e32832 c1776
10. Schechter M, do Lago RF, Mendelsohn AB, Moreira RI, Moulton LH, Harrison LH. Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. J Acquir Immune Defic Syndr 2004; 35: 519-25. doi:10.1097/00126334-200404150-00010 (Pubitemid 38420661)
11. Martin JN, Roland ME, Neilands TB, Krone MR, Bamberger JD, Kohn RP, et al. Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. AIDS 2004; 18: 787-92. doi:10.1097/00002030-200403260-00010 (Pubitemid 38535007)
12. Roland ME, Neilands TB, Krone MR, Katz MH, Franses K, Grant RM, et al. Seroconversion following nonoccupational postexposure prophylaxis against HIV. Clin Infect Dis 2005; 41: 1507-13. doi:10.1086/497268 (Pubitemid 41579997)
13. NPEP Reference Group, Savage J. National guidelines for post-exposure prophylaxis after non-occupational exposure to HIV. Sex Health 2007; 4: 277-83. doi:10.1071/SH07067 (Pubitemid 350158756)
14. Centers for Disease Control and Prevention. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep 2005; 54: 1-19.
15. Australasian Society for HIV Medicine. Literature review for the Australian guidelines for post-exposure prophylaxis after non-occupational exposure to HIV. ASHM J Club 2006; 15: 1-32. Available online at: http://www.ashm.org.au/images/publications/guidelines/jc-2006-10.pdf [verified September 2010].
16. Horyniak D, Stoove M, Yohannes K, Breschkin A, Carter T, Hatch B, et al. The impact of immigration on the burden of HIV infection in Victoria, Australia. Sex Health 2009; 6: 123-8. doi:10.1071/SH08088
17. Goller J, Hellard M, Lim M, Leslie D, Fairley C, Higgins N, et al. Monitoring HIV Incidence among men who have sex with men in Victoria, Australia. 4th IAS Conference in HIV Pathogenesis, Treatment and Prevention; 2007 July 22-25; Sydney, Australia; 2007.
18. Jin F, Crawford J, Prestage GP, Zablotska I, Imrie J, Kippax SC, et al. Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS 2009; 23: 243-52. doi:10.1097/QAD.0b013e32831fb51a
19. Poynten IM, Jin F, Prestage GP, Kaldor JM, Kippax S, Grulich AE. Defining high HIV incidence subgroups of Australian homosexual men: implications for conducting HIV prevention trials in low HIV prevalence settings. HIV Med.
20. Prestage G, Jin F, Zablotska I, Imrie J, Kaldor JM, Grulich AE. Trends in HIV prevalence among homosexual and bisexual men in eastern Australian states. Sex Health 2008; 5: 103-7. doi:10.1071/SH07074 (Pubitemid 351786443)
21. Frankland A, Zablotska I, Prestage G, Batrouney C, Kennedy M, Clift P, et al. Gay Community Periodic Survey: Melbourne 2008 (GCPS Report 3/2008). Sydney: National Centre in HIV Social Research, The University of New South Wales; 2008.
22. Zablotska I, Frankland A, Prestage G, Down I, Ryan D. Gay Community Periodic Survey: Sydney, February 2008. Sydney: National Centre in HIV Social Research, The University of New South Wales; 2008.